Medical Device Manufacturers Are Outsourcing Sterilization. Which Service Providers Are Ready for the Next Challenge?

Sterilization is one of the most critical stages in medical device manufacturing. Surgical instruments, implants, catheters, syringes and other sterile medical products must undergo validated processes before they can be released for use.

However, building and maintaining an in-house sterilization facility requires significant investment in specialised equipment, infrastructure, technical expertise, quality systems and regulatory compliance. As a result, many manufacturers use contract sterilization providers to process their products at dedicated off-site facilities.

This business model is creating opportunities for companies offering ethylene oxide sterilization, radiation processing, alternative sterilization technologies, validation and laboratory testing.

For medical device manufacturers, the priority is not simply finding an external sterilization facility. It is securing reliable capacity, consistent processing quality and a service partner capable of supporting regulatory requirements throughout the product lifecycle.

What Is Off-Site Sterilization?

Off-site or contract sterilization involves outsourcing the sterilization of medical devices or pharmaceutical products to an external specialist provider.

The manufacturer sends products to a qualified facility, where the service provider carries out the agreed sterilization process. Products are then released and returned according to the established procedures and quality requirements.

Manufacturers may outsource sterilization to:

• Avoid the capital expenditure associated with building dedicated facilities.

• Access specialised sterilization technologies.

• Use external technical expertise for process development and validation.

• Increase production flexibility during periods of high demand.

• Support entry into new geographic markets.

• Reduce the operational burden of maintaining sterilization equipment and facilities.

The model is particularly relevant for manufacturers producing single-use medical devices, surgical products, implants and sterile pharmaceutical packaging.

Download Customized Sample: https://www.towardshealthcare.com/download-sample/6571 

Which Sterilization Technologies Are Used?

The appropriate method depends on product materials, design, packaging, load configuration, temperature sensitivity and compatibility with the sterilization process.

No single technology is appropriate for every medical device. Manufacturers must evaluate material compatibility, packaging performance, process effectiveness and potential effects on product functionality before selecting a method.

EtO remains important for devices that cannot tolerate high temperatures or radiation. Gamma and electron beam processing can support suitable products, while X-ray offers another radiation-based option. Alternative methods such as VHP and nitrogen dioxide are also receiving attention as manufacturers assess their sterilization strategies.

The FDA recognises VHP as an established Category A sterilization process for relevant sterile-device 510(k) submissions following its January 2024 guidance update.

Why Are Manufacturers Increasingly Dependent on Contract Sterilization?

1. High infrastructure requirements

Sterilization facilities require specialised equipment, environmental controls, monitoring systems, qualified personnel and ongoing maintenance. Contract providers allow manufacturers to access these capabilities without building every process internally.

2. Greater demand for specialised technologies

Different medical devices require different sterilization methods. A manufacturer may need EtO for one product family and radiation processing for another. External providers offer access to multiple technologies through specialised facilities.

3. Regulatory and validation complexity

Sterilization is a validated manufacturing process. Manufacturers must maintain evidence that the selected method consistently achieves the required sterility outcome without damaging the product or its packaging.

Specialist providers can support process development, validation, routine monitoring and testing.

4. Production flexibility

Outsourcing can help manufacturers manage changing production volumes and access additional processing capacity. It can also reduce dependence on a single in-house facility, provided alternative suppliers and qualified processes are available.

Which Companies Are Competing in Contract Sterilization?

The competitive landscape includes global sterilization networks, specialist radiation providers and companies offering integrated laboratory and validation services.

STERIS AST: A Broad Contract Sterilization Portfolio

STERIS AST provides contract sterilization and microbial reduction services for medical device, pharmaceutical and other industries.

Its portfolio includes EtO, gamma, electron beam, X-ray, VHP and steam sterilization. The company also offers laboratory testing and technical support for sterilization validation and routine processing.

This range allows customers to evaluate different sterilization technologies within one service network.

Sterigenics: A Multi-Technology Global Network

Sterigenics, part of Sotera Health, provides contract sterilization through facilities across multiple regions.

Its technologies include EtO, gamma, electron beam, X-ray and nitrogen dioxide sterilization. The company also provides process development, validation and laboratory services at selected locations.

Sterigenics reports a network of 49 facilities across 13 countries, supporting customers in medical devices, pharmaceuticals and other industries.

Its geographic network is relevant to manufacturers seeking processing capacity closer to production or distribution hubs.

Medistri: Combining Sterilization and Laboratory Services

Medistri provides contract sterilization, validation and laboratory testing services.

Its capabilities include EtO and steam sterilization, with validation activities aligned with standards such as ISO 11135 for EtO and ISO 17665 for moist heat sterilization.

The company also provides testing and technical documentation to help manufacturers assess process performance and product compatibility.

This integrated approach can be useful for manufacturers that want to coordinate sterilization processing and supporting quality activities through one provider.

E-BEAM Services: Specialised Electron Beam Processing

E-BEAM Services focuses on electron beam technology for sterilization and other industrial processing applications.

The company states that its quality management system is certified to ISO 13485:2016 and that its sterilization services meet applicable requirements of EN ISO 11137-1. Its facilities are FDA-registered and subject to routine inspections, according to its published information.

Its specialised focus makes it relevant for manufacturers evaluating electron beam processing as an alternative to other sterilization methods.

What Regulatory Responsibilities Apply When Sterilization Is Outsourced?

Outsourcing sterilization does not remove the medical device manufacturer's responsibility for the finished product.

Under the FDA's regulatory framework, contract sterilizers are responsible for applicable quality requirements covering the services they perform. The finished device manufacturer retains overall responsibility for the safety and effectiveness of the device and must maintain appropriate control over its contractors.

The FDA's inspection guidance identifies requirements involving sterilization process controls, validation responsibilities, records, personnel qualifications and written agreements between manufacturers and contract sterilizers.

Manufacturers should establish clear agreements covering:

• Responsibility for process development and validation.

• Routine monitoring and batch documentation.

• Acceptance criteria and product release.

• Change control and revalidation.

• Deviations, investigations and corrective actions.

• Supplier audits and access to quality records.

• Product handling, transport and traceability.

For manufacturers operating in India, the CDSCO issued a communication dated June 24, 2025, addressing the regulatory requirements for outsourcing medical device sterilization under the Medical Devices Rules, 2017.

Regulatory requirements vary by jurisdiction and product category, so manufacturers must evaluate the applicable rules in each target market.

Where Does the Contract Sterilization Industry Face Challenges?

1. Limited access to processing capacity

Manufacturers can face delays when qualified facilities have limited availability, particularly for specialised technologies or specific product configurations. Dependence on a small number of approved facilities can also increase supply-chain risk.

2. EtO emission and environmental requirements

EtO facilities face increasing attention around emissions, worker safety and environmental controls. Providers must invest in appropriate emission-control systems, monitoring and regulatory compliance while maintaining reliable processing operations.

3. Material and packaging compatibility

Sterilization can affect polymers, adhesives, electronic components, coatings and packaging materials. A process that achieves the required sterility outcome may still be unsuitable if it changes product functionality or packaging integrity.

4. Complex validation requirements

Each product or product family requires an appropriate validation strategy. Differences in product design, packaging, loading patterns and manufacturing conditions can affect process qualification and routine performance.

5. Geographic concentration and logistics

Sterilization facilities are not evenly distributed across regions. Transporting products to distant sites can increase lead times, logistics costs and inventory requirements.

Business Opportunities for Sterilization Service Providers

The industry's challenges create opportunities for existing providers and new entrants with specialised technical capabilities.

• Alternative sterilization technologies: Investment in X-ray, VHP, nitrogen dioxide and other qualified processes can help expand options for manufacturers.

• Regional processing facilities: Additional capacity near medical device manufacturing clusters can reduce transportation requirements and supply-chain delays.

• Integrated validation and testing: Providers can combine sterilization, bioburden testing, sterility testing, residual testing and process validation.

• Capacity expansion partnerships: Long-term agreements with medical device manufacturers can support investment in dedicated processing capacity.

• Specialised product processing: Services designed for implants, complex devices, sensitive polymers and pharmaceutical products can create differentiated offerings.

• Digital quality and traceability: Improved batch records, process monitoring, data management and customer visibility can strengthen service reliability.

For investors, important evaluation factors include facility utilisation, technology mix, geographic coverage, regulatory inspection history, customer concentration, capital expenditure and long-term service agreements.

What Should Medical Device Manufacturers Evaluate Before Selecting a Provider?

A low processing price does not necessarily translate into a reliable sterilization partnership. Manufacturers should evaluate providers against technical, operational and regulatory criteria.

Manufacturers should also assess whether a provider can support future product launches, additional product families and changes in production volumes.

How Towards Healthcare Supports Industry Decision-Making

Towards Healthcare supports medical device manufacturers, investors and healthcare suppliers through structured company and competitive intelligence.

Its capabilities can help decision-makers assess:

• Complete Master Datasets: Contract sterilization companies, facility locations, technologies and service portfolios.

• Competitive Quadrants: Comparison of providers based on technology coverage, geographic presence and service capabilities.

• Customized Dashboards: Tracking facility expansions, technology investments, partnerships and company developments.

• Buyer Identification: Identifying medical device manufacturers, pharmaceutical companies and potential sterilization-service customers.

• GTM Strategy: Evaluating regional opportunities, target customer segments and partnership potential.

Off-site sterilization is becoming an important part of the medical device manufacturing ecosystem. As manufacturers seek dependable processing capacity and specialised technical support, contract providers will need to demonstrate more than access to sterilization equipment.

The strongest service propositions will combine validated processes, reliable capacity, strong quality systems, geographic flexibility and transparent customer partnerships.

Explore off-site sterilization company intelligence, facility benchmarking and competitive opportunities with Towards Healthcare.